Home
About
FAQ
History (0)
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Feldman, Steven
One or more keywords matched the following items that are connected to
Feldman, Steven
Item Type
Name
Academic Article
The impact of biologics on the quality of life of psoriasis patients and the economics of psoriasis care.
Academic Article
Intermittent dosing of biologics for psoriasis.
Academic Article
Novel combination regimens: biologics and acitretin for the treatment of psoriasis-- a case series.
Academic Article
Adverse events from systemic therapies for psoriasis are common in clinical practice.
Academic Article
Medication adherence and health care costs associated with biologics in Medicaid-enrolled patients with psoriasis.
Academic Article
Do utilization management controls for phototherapy increase the prescription of biologics?
Academic Article
Increasing use of more potent treatments for psoriasis.
Academic Article
Clobetasol propionate spray 0.05% add-on therapy to a stable regimen of biologic treatment in patients with moderate to very severe plaque psoriasis.
Academic Article
Medication use and associated health care outcomes and costs for patients with psoriasis in the United States.
Academic Article
Would elimination of copayments for phototherapy decrease the cost of treating psoriasis with systemic biologics? A cost analysis.
Academic Article
Outcomes associated with the use of biologic agents in moderate to severe psoriasis.
Academic Article
Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics.
Academic Article
Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 2. Psoriatic arthritis: overview and guidelines of care for treatment with an emphasis on the biologics.
Academic Article
Management and costs of severe psoriasis: the role of new biologics.
Academic Article
Comparative efficacy of biologics in psoriasis: a review.
Concept
Biological Products
Academic Article
Adherence to adalimumab in patients with moderate to severe psoriasis.
Academic Article
The cost of biologics for psoriasis is increasing.
Academic Article
The 5-point Investigator's Global Assessment (IGA) Scale: A modified tool for evaluating plaque psoriasis severity in clinical trials.
Academic Article
Biologics and biosimilars.
Academic Article
Economic and Comorbidity Burden Among Patients with Moderate-to-Severe Psoriasis.
Academic Article
Even well-controlled psoriasis patients have unmet treatment needs regardless of disease severity.
Academic Article
Costs of Common Psoriasis Medications, 2010-2014.
Academic Article
Review of maintenance of response to psoriasis treatments.
Academic Article
Current challenges and emerging drug delivery strategies for the treatment of psoriasis.
Academic Article
Dermatologists: Collaborating With Payers to Optimize Coverage Policies.
Academic Article
Psoriasis, Depression, and Inflammatory Overlap: A Review.
Academic Article
Budget impact model in moderate-to-severe psoriasis vulgaris assessing effects of calcipotriene and betamethasone dipropionate foam on per-patient standard of care costs.
Academic Article
Healthcare costs in psoriasis and psoriasis sub-groups over time following psoriasis diagnosis.
Academic Article
Severe and acute complications of biologics in psoriasis.
Academic Article
Adherence to biologics in patients with psoriasis.
Academic Article
Biologics monitoring: incongruity between recommendations and clinician monitoring trends.
Academic Article
Adherence and resource use among psoriasis patients treated with biologics.
Academic Article
Comparison of the cost-effectiveness of biologic drugs used for moderate-to-severe psoriasis treatment in the United States.
Academic Article
The budget impact of brodalumab for the treatment of moderate-to-severe plaque psoriasis on US commercial health plans.
Academic Article
Real-world US healthcare costs of psoriasis for biologic-naive patients initiating apremilast or biologics.
Academic Article
A systematic review of herpes zoster incidence and consensus recommendations on vaccination in adult patients on systemic therapy for psoriasis or psoriatic arthritis: From the Medical Board of the National Psoriasis Foundation.
Academic Article
Patient-reported outcomes are important elements of psoriasis treatment decision making: A discrete choice experiment survey of dermatologists in the United States.
Academic Article
Treatment patterns and costs among biologic-naive patients initiating apremilast or biologics for psoriatic arthritis.
Academic Article
Tracking the price of existing biologics when drugs enter the market.
Academic Article
Relative efficacy of systemic treatments for atopic dermatitis.
Academic Article
A safety review of recent advancements in the treatment of psoriasis: analysis of clinical trial safety data.
Academic Article
Investigational drugs in phase II clinical trials for moderate to severe plaque psoriasis - potential new treatments on the horizon.
Academic Article
Can We Tell Patients That IL-23 and TNF-a Inhibition Are "Natural" Ways to Treat Psoriasis?
Academic Article
An update on the topical and oral therapy options for treating pediatric atopic dermatitis.
Academic Article
Current biological therapies for use in HIV-positive patients with psoriasis: case report of gesulkumab used and review.
Academic Article
The complexity of adverse event assessment and counseling for patients on biologic treatment.
Academic Article
The journey for US psoriasis patients prescribed a topical: a retrospective database evaluation of patient progression to oral and/or biologic treatment.
Academic Article
Current pharmacological treatment guidelines for psoriasis and psoriatic arthritis.
Academic Article
Treatment Adherence and Persistence of Seven Commonly Prescribed Biologics for Moderate to Severe Psoriasis and Psoriatic Arthritis in a U.S. Commercially Insured Population.
Search Criteria
Biological Products